Globus Medical Inc. (GMED) is a leading medical device company which specializes in the design, development, and commercialization of musculoskeletal solutions. The company was founded in 2003 by an accomplished orthopedic expert, David Paul, and has its headquarters located in Audubon, Pennsylvania, United States. The company has a strong presence in the market, serving customers in over 30 countries worldwide within a diverse portfolio of products used to support the spine and trauma surgeries.
Globus Medical Inc. is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol 'GMED'. The company has a well-established reputation for its continual innovation and state-of-the-art technology. Its primary mission is to improve the quality of life for patients suffering from musculoskeletal diseases by providing innovative and high-quality medical solutions.
Globus Medical Inc. boasts a broad product portfolio that includes fusion, minimally invasive, and motion preservation technologies. These products include the Secure-C cervical artificial disc for treating degenerative disc diseases and the CREO® Thoracolumbar System for spinal surgeries. The company also provides disruptive and incremental technology solutions, which are based on patient needs such as the ExcelsiusGPS, a revolutionary robotic navigation platform for spine surgeries.
Furthermore, Globus Medical Inc.'s main distinguishing strength lies within its INNOVEX (Innovation, Excellence, and Acceleration) platform. This is a highly integrated, collaborative platform that allows for rapid development, rigorous validation, and fast commercial launch of new innovative products.
Globus Medical Inc. has a dedicated team of professionals who are committed to research and development, striving to bring forward innovative technologies and breakthrough procedures. As a leading player in the sector, the company has an unwavering commitment to clinical research, education, and medical advancement, which have been evident in the numerous patents and FDA-approved devices to their name.
Interestingly, in its zeal to further expand its offerings, Globus Medical Inc. has supplemented its growth strategy through strategic acquisitions and partnerships. The company has acquired several businesses, including the trauma division of Alphatec Spine and Swiss-based robotic developer, KB Medical.
No doubt, Globus Medical’s commitment to research and development, exceptional product portfolio, global reach, and sound business strategies have earned it a notable position in the medical device sector. In the future, the company aims to continue this trajectory, ensuring that it remains at the forefront of technological advancements in the medical device industry.